<DOC>
	<DOC>NCT00347841</DOC>
	<brief_summary>To evaluate the IOP-lowering efficacy of bimatoprost 0.03% in patients found to be low-responders to latanoprost therapy.</brief_summary>
	<brief_title>Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost</brief_title>
	<detailed_description />
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>· Male or female &gt; 18 years of age Documented lowresponder to latanoprost therapy as delineated in the outline above. Diagnosis of openangle glaucoma or ocular hypertension Ability to provide informed consent and likely to complete all study visits · Known contraindication to bimatoprost or any component of any study medication Uncontrolled systemic disease Active ocular disease other than glaucoma or ocular hypertension Required use of ocular medications other than the study medications during the study (intermittent use of artificial tear solutions will be permitted) History of intraocular surgery within the last 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>